Most sleep technology is designed to tell you how you slept. DUSQ believes the next generation of sleep technology should help you sleep better while you are still asleep.
Weeks after launching on Kickstarter, DUSQ crossed $1 million in funding, becoming the fastest Indian healthtech company to hit that number on the platform. According to the company, the campaign surpassed the amount raised by Ultrahuman's original Ring Kickstarter. As the campaign nears its close, the funding number has climbed past 11,000% of its original goal. The response went far beyond expectations, turning the campaign into one of India's biggest healthtech Kickstarter successes.
Where It Started
Dr. Siddhant Bhargava, DUSQ's co-founder and CEO, did not arrive at sleep science by accident. He survived Lupus as a teenager and cancer in his twenties, two experiences that pushed him to spend a decade working at the intersection of clinical medicine and consumer health. Those years convinced him that poor sleep was not a side effect of chronic illness. It was closer to the root of it.
That conviction became the starting point for a company built less around a product idea and more around a biological question: what if sleep problems could be treated the same way a doctor treats an active condition, by intervening in real time, instead of only measuring the aftermath the next morning.
The Problem With Sleep Tech
The sleep tracking market is not short of players. Oura, Whoop, and Garmin have built entire categories around scoring how well someone slept. Devices like Somnee and Pulsetto go a step further, offering a fixed stimulation routine before bed to help someone fall asleep.
DUSQ's founding team looked at that landscape and identified a gap none of them were solving. Every existing device stopped working the moment a person fell asleep. None of them responded to what was actually happening in the body through the night, when most disruptions occur. A good sleep score the next morning does not undo a night of fragmented rest. The team's thesis was that real recovery required a system that stayed active for the entire sleep cycle, not just before it.
Why Now
The timing matters. Sleep deprivation has been widely described as a public health issue for years, and the wearable boom of the last decade means most people who care about their health already own a tracker. That created an odd gap: millions of people now know exactly how badly they slept, with no product actually doing anything about it. DUSQ's bet is that once tracking becomes commonplace, the next wave in the category will not be a better dashboard. It will be a device that acts.
The Team Behind It
DUSQ was founded in 2023, and while Bhargava leads as CEO, the company was built by a full founding team, each owning a distinct piece of the problem.
Building a product like DUSQ required expertise across medicine, product design, algorithms, biotech, and consumer branding, and each founder took ownership of one layer of the system. Shalmali Kadu leads product, shaping how the science translates into something people can actually wear and understand. Mitansh Khurana leads the technology stack that holds the system together. Animesh Kumar heads biotech, translating raw physiological signals into something actionable. Hrithik Jaiswal leads the algorithms that process those signals in real time and decide how the device should respond.
Gursakhi Lugani joined as Chief Taste Officer, bringing a second founder's perspective to the table. She had already taken a consumer brand from zero to eleven countries before it was acquired, and her role at DUSQ has been shaping how a deeply technical product feels, looks, and is experienced by customers, not just something that works.
This is not a story of one founder with a supporting cast. It is closer to six specialists, Bhargava included, who each had to solve a piece of the same hard problem before any of it could work as a single device.
The Product and the Science
DUSQ's device weighs 12 grams and sits behind the ear. It is built around what the company calls a closed-loop sleep regulation system, a phrase that describes exactly what it is meant to do: sense a disruption and respond to it, in the same loop, without waiting for morning.
Think of it less like a fitness tracker and more like a thermostat for sleep. A thermostat does not just tell you the room got cold, it turns the heat on. DUSQ works the same way. It reads the body's autonomic nervous system through skin sensors, picking up the subtle signals that show up right before sleep is about to be disrupted, often before the person is even aware of it. The moment it senses that disruption, it responds with gentle nerve stimulation behind the ear, nudging the body back toward deeper sleep instead of simply logging the interruption for a report the next morning.
Central to this approach is a metric DUSQ calls SQ, or Sleep Quotient. Where a typical sleep score describes what already happened, SQ is built to measure the body's capacity to produce sleep in the first place, a subtle but important difference for a company trying to move the category from observation to intervention.
Behind the product sits nearly two years of research and more than 50 million physiological data points collected inside DUSQ's own sleep laboratory. The company has completed one clinical trial, with a second currently underway, and holds CDSCO certification in India along with an FDA-cleared stimulation modality for insomnia. According to DUSQ, its trials have shown a 31% increase in deep sleep, a 38% improvement in heart rate variability, and 22% fewer night-time awakenings, though these results come from the company's own reported data.
DUSQ did not start out as DUSQ. The company's earlier version, InnerGize, was a stress-focused wearable that gained national attention through a three-Shark deal on Shark Tank India. That early traction proved people wanted the product, but it also revealed something the team had not fully accounted for: stress was often a symptom, and sleep was closer to the actual cause.
That realization put the team in a harder spot than it sounds.
InnerGize was already working. It had national visibility, real users, and a Shark Tank deal behind it, the kind of traction most startups spend years chasing. Walking away from a product that was gaining momentum, to rebuild the science from scratch with no guarantee it would work, was a bet on being right over being comfortable. Most teams scale what is already working. DUSQ's founders chose to step back, rebuild the science, and relaunch as a company with a narrower, harder thesis to prove.
The $1 Million Kickstarter Moment
DUSQ's US Kickstarter campaign launched on June 9, 2026, following more than 2,000 first-generation commercial users in India and a US waitlist that had already crossed 10,000 people before launch. Within days, the campaign passed $1 million, making DUSQ the fastest Indian healthtech company to hit that number on the platform. According to the company, that surpassed the roughly $500,000 raised by Ultrahuman's original Ring campaign.
The campaign has continued to climb well past its original funding target, currently sitting above 11,000% funded. Early backers have access to pricing between $229 and $349, ahead of an expected retail price of $499, with shipping planned for later in 2026.
The milestone follows a ₹24 crore (approximately $3 million) seed round led by Fireside Ventures, with participation from Antler India, Climber Capital, and angel investors including Avnish Anand, founder of CaratLane, and Shivam Puri, CEO of Cipla Health.
Where They Want to Take It
The team's ambition extends well beyond one Kickstarter campaign. Bhargava has spoken about DUSQ's goal to define and own sleep regulation as its own category over the next decade, built around the idea that the autonomic nervous system, not sleep duration or a nightly score, is the real foundation of recovery.
With a US retail launch on the horizon and the India team expanding across engineering, biotech, and growth roles, DUSQ's next test is proving that a category built inside an Indian sleep lab can hold its ground in a market crowded with well-funded, well-known names. If DUSQ is right, the future of sleep technology may not be about understanding your sleep. It may be about quietly improving it while you never notice.
The Entrepreneur Post
